Stock events for Harte-Hanks, Inc. (HHS)
Harte-Hanks, Inc.'s stock price has fluctuated over the past six months, with a 52-week range between $2.33 and $5.39. The share price declined by 44.11% from March 3, 2025, to February 27, 2026. Recent financial reports indicate revenue declines across all segments for Q4 and full-year 2024, and Q1 and Q2 2025 results showed decreased total revenue and a net loss.
Demand Seasonality affecting Harte-Hanks, Inc.’s stock price
Harte-Hanks, Inc. has historically experienced demand seasonality for its products and services, with the first quarter typically being the seasonally lowest. The company has observed a return to more seasonally reduced activity in the first quarter.
Overview of Harte-Hanks, Inc.’s business
Harte-Hanks, Inc. is a global customer experience company providing data-driven marketing, customer care, and logistics solutions. It operates through Marketing Services, Customer Care, and Fulfillment & Logistics Services segments, serving diverse industries like B2B, healthcare, and retail. The company offers strategy, data analytics, contact center solutions, and fulfillment services.
HHS’s Geographic footprint
Harte-Hanks, Inc. has a geographic presence in the United States and other countries, with the majority of its revenue generated from the United States. The company is headquartered in Chelmsford, Massachusetts, United States.
HHS Corporate Image Assessment
Harte Hanks positions itself as a global leader in customer experience solutions, focusing on partnering with clients to provide robust CX strategy, data-driven analytics, and seamless program execution to understand, attract, and engage customers. The company opened a customer care center in Greenville, South Carolina, in partnership with Samsung Electronics America in October 2025. Harte Hanks secured exclusive rights to license ADS Data Direct's Medical Ailment Database to support compliant healthcare marketing. In June 2024, the company launched "Demand Generation In a Box," a turnkey suite aimed at small and medium businesses, as part of its "Elevate" program to diversify products and expand its customer base.
Ownership
Harte-Hanks, Inc. has 33 institutional owners and shareholders, holding a total of 2,089,269 shares as of February 27, 2026. Major institutional shareholders include Blair William & Co/il, Westerly Capital Management, Llc, and Vanguard Group Inc. Top individual shareholders include Gary Stephen Rosenbach, Houston H. Harte, and Westerly Capital Management LLC. Hedge funds controlled 24% of shares, and the general public held a 29% stake.
